ÂÜÀòÂÒÂ×

Matthew Quinn is a seasoned professional in product development and research, currently serving as the Director of Product Development, Automation at Revvity since September 2023. Prior to this role, Matthew held various positions at Oxford Immunotec from August 2014 to October 2023, including Director of R&D and Sr. R&D Manager. Academic background includes a PhD in Microbiology and Immunology from the University of Rochester, complemented by a Master's degree in the same field and a Bachelor's degree in Biotechnology from Rochester Institute of Technology. Matthew's research experience includes developing a BAC based reverse genetics system for Measles virus at Northwestern University and studying dengue virus production at the University of Rochester Medical Center. Additionally, early experience includes a summer internship at Biogen Idec focusing on early stage candidate antibody characterization.